Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00206674
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 286
Not applicableUnknownNCT06362863
What this trial is testing

Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Ping An 52
Not applicableStudy completedNCT01338740
What this trial is testing

Switching From Adalimumab to Infliximab

Who this might be right for
Crohn's Disease
University Hospital, Ghent 21
Not applicableStudy completedNCT01218360
What this trial is testing

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

Who this might be right for
Crohn Disease
Merck Sharp & Dohme LLC 71
Testing effectiveness (Phase 2)Ended earlyNCT00038766
What this trial is testing

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Ferring Pharmaceuticals 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06450197
What this trial is testing

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

Who this might be right for
Moderate to Severe Crohn's Disease
AstraZeneca 120
Testing effectiveness (Phase 2)WithdrawnNCT02913508
What this trial is testing

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda
Large-scale testing (Phase 3)Ended earlyNCT01536418
What this trial is testing

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 255
Testing effectiveness (Phase 2)Ended earlyNCT01150890
What this trial is testing

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Amgen 130
Testing effectiveness (Phase 2)Study completedNCT00102921
What this trial is testing

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Amgen 70
Testing effectiveness (Phase 2)Looking for participantsNCT07483099
What this trial is testing

LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Who this might be right for
Crohn Disease
Eli Lilly and Company 60
Large-scale testing (Phase 3)Looking for participantsNCT06059989
What this trial is testing

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Who this might be right for
Inflammatory DiseaseDisease CrohnBowel Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677514
What this trial is testing

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd. 156
Not applicableStudy completedNCT02846961
What this trial is testing

Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease
Kyungpook National University Hospital 280
Post-approval studies (Phase 4)Not Yet RecruitingNCT07659353
What this trial is testing

Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed, Moderate-to-severe Crohn's Disease

Who this might be right for
Chrohn's Disease
University Hospital Schleswig-Holstein 320
Not applicableLooking for participantsNCT05428345
What this trial is testing

Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Who this might be right for
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD)
Takeda 600
Large-scale testing (Phase 3)Study completedNCT01951326
What this trial is testing

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Who this might be right for
Crohn's Disease
RedHill Biopharma Limited 331
Large-scale testing (Phase 3)Looking for participantsNCT04844606
What this trial is testing

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Who this might be right for
Ulcerative ColitisUlcerative Colitis ChronicInflammatory Bowel Diseases+1 more
Eli Lilly and Company 150
Testing effectiveness (Phase 2)WithdrawnNCT05057273
What this trial is testing

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Who this might be right for
Crohn's Disease
NImmune Biopharma
Testing effectiveness (Phase 2)Study completedNCT01203631
What this trial is testing

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Janssen Research & Development, LLC 78
Next Page